Combined Effects of IL-12 and IL-18 on the Induction of Collagen-Induced Arthritis
Open Access
- 15 June 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (12) , 6495-6502
- https://doi.org/10.4049/jimmunol.164.12.6495
Abstract
IL-18 expression has recently been detected in rheumatoid arthritis (RA) synovial membrane. We investigated the mechanisms by which IL-18-induced collagen-induced arthritis in DBA/1 mice primed intradermally with type II bovine collagen in IFA and boosted i.p. 21 days later with CII in saline. Mice were injected i.p. with rIL-12, rIL-18, or both (100 ng) during days −1 to 4 and again on days 20–24. Control mice received PBS. Mice treated with IL-12 or IL-18 alone developed significantly higher incidence and more severe disease compared with controls. These were elevated further by combination treatment with IL-12 and IL-18. The cytokine treatments led to markedly enhanced synovial hyperplasia, cellular infiltration, and cartilage erosion compared with controls. Cytokine-treated mice produced significantly more IFN-γ, TNF-α, and IL-6 than the controls. Interestingly, IL-18-treated mice produced more TNF-α and IL-6, but less IFN-γ, compared with mice treated with IL-12. Furthermore, splenic macrophages from DBA/1 mice cultured in vitro with IL-18, but not IL-12, produced substantial amounts of TNF-α. Mice treated with IL-18 or IL-18 plus IL-12 produced markedly more IgG1 and IgG2a anti-collagen Ab compared with controls, whereas IL-12 treatment only led to an enhanced IgG2a response. Together these results demonstrate that IL-18 can promote collagen-induced inflammatory arthritis through mechanisms that may be distinct from those induced by IL-12.Keywords
This publication has 45 references indexed in Scilit:
- Interleukin-18Methods, 1999
- Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritisEuropean Journal of Immunology, 1999
- Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: Possible involvement of endogenous interleukin-10 and tumor necrosis factor ?Arthritis & Rheumatism, 1999
- IL-18, a novel immunoregulatory cytokine, is upregulated in Crohn's disease: Expression and localization in intestinal mucosal cellsGastroenterology, 1998
- Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast FormationThe Journal of Experimental Medicine, 1997
- Role of interleukin‐4 and interleukin‐10 in murine collagen‐induced arthritis. Protective effect of interleukin‐4 and interleukin‐10 treatment on cartilage destructionArthritis & Rheumatism, 1997
- Reduced incidence and severity of collagen‐induced arthritis in interleukin‐12‐deficient miceEuropean Journal of Immunology, 1996
- Shift toward T lymphocytes with a T helper 1 cytokine‐secretion profile in the joints of patients with rheumatoid arthritisArthritis & Rheumatism, 1996
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995